BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30471093)

  • 1. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β
    Dal Monte M; Calvani M; Cammalleri M; Favre C; Filippi L; Bagnoli P
    Br J Pharmacol; 2019 Jul; 176(14):2496-2508. PubMed ID: 30471093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β
    Calvani M; Bruno G; Dal Monte M; Nassini R; Fontani F; Casini A; Cavallini L; Becatti M; Bianchini F; De Logu F; Forni G; la Marca G; Calorini L; Bagnoli P; Chiarugi P; Pupi A; Azzari C; Geppetti P; Favre C; Filippi L
    Br J Pharmacol; 2019 Jul; 176(14):2509-2524. PubMed ID: 30874296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced desensitisation of β
    Okeke K; Angers S; Bouvier M; Michel MC
    Br J Pharmacol; 2019 Jul; 176(14):2539-2558. PubMed ID: 30809805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β
    Igawa Y; Aizawa N; Michel MC
    Br J Pharmacol; 2019 Jul; 176(14):2525-2538. PubMed ID: 30868554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac β
    Arioglu-Inan E; Kayki-Mutlu G; Michel MC
    Br J Pharmacol; 2019 Jul; 176(14):2482-2495. PubMed ID: 30801686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
    Zhao WB; Lu Q; Nguyen MN; Su Y; Ziemann M; Wang LN; Kiriazis H; Puthalakath H; Sadoshima J; Hu HY; Du XJ
    Br J Pharmacol; 2019 Jul; 176(14):2465-2481. PubMed ID: 30932177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Adrenoceptor Blockade for Infantile Hemangioma Therapy: Do β3-Adrenoceptors Play a Role?
    Escarcega González CE; González Hernández A; Villalón CM; Rodríguez MG; Marichal Cancino BA
    J Vasc Res; 2018; 55(3):159-168. PubMed ID: 29936502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
    Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
    Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
    Horinouchi T; Koike K
    J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of β-Blockers in Melanoma.
    De Giorgi V; Geppetti P; Lupi C; Benemei S
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):17-26. PubMed ID: 31482435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.
    Dal Monte M; Casini G; Filippi L; Nicchia GP; Svelto M; Bagnoli P
    J Mol Med (Berl); 2013 Dec; 91(12):1407-19. PubMed ID: 23907236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors.
    Schnabel P; Maack C; Mies F; Tyroller S; Scheer A; Böhm M
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):466-71. PubMed ID: 11026647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression.
    Calvani M; Pelon F; Comito G; Taddei ML; Moretti S; Innocenti S; Nassini R; Gerlini G; Borgognoni L; Bambi F; Giannoni E; Filippi L; Chiarugi P
    Oncotarget; 2015 Mar; 6(7):4615-32. PubMed ID: 25474135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta3-adrenoceptors in the cardiovascular system.
    Gauthier C; Langin D; Balligand JL
    Trends Pharmacol Sci; 2000 Nov; 21(11):426-31. PubMed ID: 11121573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that (+/-)-carteolol-induced relaxation is mediated by beta2-adrenoceptors but not by beta3-adrenoceptors in the guinea pig taenia caecum.
    Horinouchi T; Koike K
    J Smooth Muscle Res; 2000 Oct; 36(5):145-53. PubMed ID: 11286298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries.
    Kozłowska H; Schlicker E; Kozłowski M; Siedlecka U; Laudański J; Malinowska B
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):76-82. PubMed ID: 15965358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical beta-adrenoceptors mediating relaxation in the human colon: functional evidence for beta3-rather than beta4-adrenoceptors.
    de Ponti F; Modini C; Gibelli G; Crema F; Frigo G
    Pharmacol Res; 1999 May; 39(5):345-8. PubMed ID: 10328991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.
    Du XJ; Zhao WB; Nguyen MN; Lu Q; Kiriazis H
    Br J Pharmacol; 2019 Jul; 176(14):2449-2464. PubMed ID: 30756388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of beta3-adrenoceptors in the guinea pig gastric fundus: stereoselectivity, beta-adrenoceptor alkylation, and structure-activity relationship.
    Horinouchi T; Koike K
    Can J Physiol Pharmacol; 2001 Dec; 79(12):985-95. PubMed ID: 11824942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.